Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year